Cục Thông tin KH&CN Quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 10/9 đến ngày 17/92021. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài.
SCIENCEDIRECT
1. Prediction of False-Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Results in a High-Throughput Open-Platform System
The Journal of Molecular Diagnostics, 8 June 2021, Volume 23, Issue 9, Pages 1085-1096
Ryan J. Martinez, Nathan Pankratz, Andrew C. Nelson
https://www.sciencedirect.com/science/article/pii/S1525157821001665/pdfft?md5=65d7f7726a5815c6545c341dc204e624&pid=1-s2.0-S1525157821001665-main.pdf
2. COVID-19 vaccines: Current evidence and considerations
Metabolism Open, 11 September 2021, Volume 12, Article 100124
Alireza Tavilani, Ebrahim Abbasi, Zahra Asefy
https://www.sciencedirect.com/science/article/pii/S2589936821000487/pdfft?md5=d3cbfd1ab495b540cb8f230447d21241&pid=1-s2.0-S2589936821000487-main.pdf
3. Design and application of nanoparticles as vaccine adjuvants against human corona virus infection
Journal of Inorganic Biochemistry, 29 March 2021, Volume 219, Article 111454
Lichun Mao, Ziwei Chen, Chunying Chen
https://www.sciencedirect.com/science/article/pii/S016201342100101X
4. Towards a novel peptide vaccine for Middle East respiratory syndrome coronavirus and its possible use against pandemic COVID-19
Journal of Molecular Liquids, 6 November 2020, Volume 324, Article 114706
Salman Khan, Bilal Shaker, Wasim Sajjad
https://www.sciencedirect.com/science/article/abs/pii/S0167732220369488
5. Vaccine hesitancy among people with multiple sclerosis
Multiple Sclerosis and Related Disorders, 2 September 202, Volume 56, Article 103236
Siew Mei Yap, Mahmood Al Hinai, Christopher McGuigan
https://www.sciencedirect.com/science/article/abs/pii/S2211034821005034
6. A comprehensive analysis of the efficacy and safety of COVID-19 vaccines
Molecular Therapy, 6 August 2021, Volume 29, Issue 9, Pages 2794-2805
Changjing Cai, Yinghui Peng, Hong Shen
https://www.sciencedirect.com/science/article/pii/S1525001621003956/pdfft?md5=d076570807615680fdeba6a50a146c59&pid=1-s2.0-S1525001621003956-main.pdf
7. The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis
The Journal of Allergy and Clinical Immunology: In Practice, 20 April 2021, Volume 9, Issue 7, Pages 2556-2561
Marcus Shaker, Elizabeth Phillips, Matthew Greenhawt
https://www.sciencedirect.com/science/article/abs/pii/S2213219821004554
8. Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19
Molecular Therapy, 23 April 2021, Volume 29, Issue 8, Pages 2412-2423
Stefania Capone, Angelo Raggioli, Alessandra Vitelli
https://www.sciencedirect.com/science/article/abs/pii/S1525001621002100
9. In-silico immunoinformatic analysis of SARS-CoV-2 virus for the development of putative vaccine construct
Immunobiology, 28 August 2021, Volume 226, Issue 5, Article 152134
Abhishek Sharma, Surinder Pal, Ashok Kumar
https://www.sciencedirect.com/science/article/pii/S0171298521000826/pdfft?md5=9abb72568b71bf6d665d5d2f7315c7a5&pid=1-s2.0-S0171298521000826-main.pdf
10. Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects
Therapies, 7 May 2021, Volume 76, Issue 4, Pages 305-309
Antoine Pariente, Julien Bezin
https://www.sciencedirect.com/science/article/abs/pii/S0040595721001165
11. Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens
Med, 14 August 2021, Volume 2, Issue 9, Pages 1050-1071.e7
Vijayashree Mysore, Xavier Cullere, Tanya N. Mayadas
https://www.sciencedirect.com/science/article/pii/S2666634021002890/pdfft?md5=a943122b2d981b03101200c907da24e9&pid=1-s2.0-S2666634021002890-main.pdf
12. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing
The Journal of Allergy and Clinical Immunology: In Practice, 22 June 2021, Volume 9, Issue 9, Pages 3308-3320.e3
Anna R. Wolfson, Lacey B. Robinson, Aleena Banerji
https://www.sciencedirect.com/science/article/pii/S2213219821006759/pdfft?md5=ec760d227d1ee85e50f3436e4d8d7336&pid=1-s2.0-S2213219821006759-main.pdf
13. Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
Journal of Allergy and Clinical Immunology, 1 June 2021, Volume 148, Issue 3, Pages 739-749
David Hagin, Tal Freund, Natalia T. Freund
https://www.sciencedirect.com/science/article/abs/pii/S0091674921008873
14. Cutaneous adverse effects of the available COVID-19 vaccines
Clinics in Dermatology, 27 April 2021, Volume 39, Issue 3, Pages 523-531
Georgi Bogdanov, Ivan Bogdanov, Nikolai Tsankov
https://www.sciencedirect.com/science/article/abs/pii/S0738081X21000614
15. An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
Cell Host & Microbe, 7 August 2021, Volume 29, Issue 9,Pages 1437-1453.e8
Nerea Zabaleta, Wenlong Dai, Luk H. Vandenberghe
https://www.sciencedirect.com/science/article/pii/S1931312821003784/pdfft?md5=e75f3d4cf120e3e07827846375737f54&pid=1-s2.0-S1931312821003784-main.pdf
16. Diabetes and COVID-19: Mechanism of pneumonia, treatment strategy and vaccine
Metabolism Open, 7 September 2021, Volume 11, Article 100122
Ebrahim Abbasi, Fatemeh Mirzaei, Iraj Khodadadi
https://www.sciencedirect.com/science/article/pii/S2589936821000463/pdfft?md5=271e91010470ed3d35f53a7f47662a02&pid=1-s2.0-S2589936821000463-main.pdf
17. Inverted repeats in coronavirus SARS-CoV-2 genome manifest the evolution events
Journal of Theoretical Biology, 31 August 2021, Volume 530, Article 110885
Changchuan Yin, Stephen S. -T. Yau
https://www.sciencedirect.com/science/article/pii/S0022519321003040/pdfft?md5=49b80f85d1a0c01e84ba96cbec3d92ce&pid=1-s2.0-S0022519321003040-main.pdf
18. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients
Journal of Infection and Public Health, 27 May 2021, Volume 14, Issue 7, Pages 845-851
Yi Chen, Ping Li, Guangwen Cao
https://www.sciencedirect.com/science/article/pii/S1876034121001209/pdfft?md5=bdade96d3619231279ecc4f4bd321445&pid=1-s2.0-S1876034121001209-main.pdf
19. Estimation of the main conditions in (SARS-CoV-2) Covid-19 patients that increase the risk of death using Machine learning, the case of Mexico
Results in Physics, 24 June 2021, Volume 27, Article 104483
José A. Guzmán-Torres, Elia M. Alonso-Guzmán, Gerardo Tinoco-Guerrero
https://www.sciencedirect.com/science/article/pii/S2211379721005969/pdfft?md5=2512bc2da776a96993c51543b81ae321&pid=1-s2.0-S2211379721005969-main.pdf
20. A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
Cell Reports, 7 July 2021, Volume 36, Issue 4, Article 109433
Federico Bertoglio, Viola Fühner, Michael Hust
https://www.sciencedirect.com/science/article/pii/S2211124721008500/pdfft?md5=f9fab3f4384354dfa777a407482ae703&pid=1-s2.0-S2211124721008500-main.pdf
21. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Journal of Allergy and Clinical Immunology, 20 November 2020, Volume 147, Issue 2, Pages 545-557.e9
Carlo Cervia, Jakob Nilsson, Onur Boyman
https://www.sciencedirect.com/science/article/pii/S0091674920316237/pdfft?md5=729ef0351cea7453f557486bd7a85494&pid=1-s2.0-S0091674920316237-main.pdf
22. Reactivation of SARS-CoV-2 infection following recovery from COVID-19
Journal of Infection and Public Health, 8 February 2021, Volume 14, Issue 5, Pages 620-627
Zhihai Chen, Wen Xie, Calvin Q. Pan
https://www.sciencedirect.com/science/article/pii/S1876034121000320/pdfft?md5=449b1fc4bc1fbaaaf6f6dce52eff7426&pid=1-s2.0-S1876034121000320-main.pdf
23. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome – A multi-omics big data study
Gene Reports, 12 August 2021, Volume 25, Article 101312
Jeganathan Manivannan, Lakshmikirupa Sundaresan
https://www.sciencedirect.com/science/article/pii/S2452014421002971/pdfft?md5=91ab2db645c883d03651abb4c730cffb&pid=1-s2.0-S2452014421002971-main.pdf
24. Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach
Computers in Biology and Medicine, 21 July 2021, Volume 136, Article 104669
Motiur Rahaman, Jaikrishna Komanapalli, Nishant Chakravorty
https://www.sciencedirect.com/science/article/pii/S0010482521004637/pdfft?md5=8f248c3828bf0c627eb89fcee1263fc8&pid=1-s2.0-S0010482521004637-main.pdf
25. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
Cell, 23 July 2021, Volume 184, Issue 18, Pages 4713-4733.e22
Carly G. K. Ziegler, Vincent N. Miao, Jose Ordovas-Montanes
https://www.sciencedirect.com/science/article/pii/S0092867421008825/pdfft?md5=c1afdb44fc87ddcbef3fd4e9c0eb3776&pid=1-s2.0-S0092867421008825-main.pdf
26. Stochastic modelling of the dynamics of infections caused by the SARS-CoV-2 and COVID-19 under various conditions of lockdown, quarantine, and testing
Results in Physics, 24 July 2021, Volume 28, Article 104573
Tiri Chinyoka
https://www.sciencedirect.com/science/article/pii/S2211379721006732/pdfft?md5=a7abd6a3f54d858f621bcb4a9b2f2aa1&pid=1-s2.0-S2211379721006732-main.pdf
27. Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients
Journal of Clinical Virology, 8 August 2021, Volume 142, Article 104943
Beatriz Olea, Eliseo Albert, David Navarro
https://www.sciencedirect.com/science/article/pii/S1386653221002109/pdfft?md5=60c98ff36f4fbc22b3ab875f939e4a79&pid=1-s2.0-S1386653221002109-main.pdf
28. Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression
Human Pathology, 4 May 2021, Volume 114, Pages 110-119
Siraj M. El Jamal, Elisabet Pujadas, William H. Westra
https://www.sciencedirect.com/science/article/pii/S0046817721000708/pdfft?md5=320c51494446b2d1aff7336157d0d3b0&pid=1-s2.0-S0046817721000708-main.pdf
29. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV
Infection, Genetics and Evolution, 6 January 2021, Volume 88, Article 104708
Jnanendra Prasad Sarkar, Indrajit Saha, Ujjwal Maulik
https://www.sciencedirect.com/science/article/abs/pii/S1567134821000058
30. Isothermal recombinase polymerase amplification-lateral flow detection of SARS-CoV-2, the etiological agent of COVID-19
Journal of Virological Methods, 2 July 2021, Volume 296, Article 114227
Thomas R. Shelite, Ashanti C. Uscanga-Palomeque, Bruno L. Travi
https://www.sciencedirect.com/science/article/pii/S016609342100166X/pdfft?md5=0846a05d74599c03f44be4a5351f4de9&pid=1-s2.0-S016609342100166X-main.pdf
31. Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19
International Journal of Pharmaceutics, 18 August 2021, Volume 607, Article 121024
Hui-Min Ho, Chiung-Yi Huang, Ming-Hsi Huang
https://www.sciencedirect.com/science/article/pii/S0378517321008309/pdfft?md5=726c5d3dc595e569e1b3a5e0c7147b74&pid=1-s2.0-S0378517321008309-main.pdf
32. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents
Journal of Ethnopharmacology, 5 June 2021, Volume 278, Article 114303
Jie Mei, Yatong Zhou, Boyang Yu
https://www.sciencedirect.com/science/article/abs/pii/S0378874121005304
33. Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis
European Journal of Pharmacology, 1 December 2020, Volume 891, Article 173781
Bilal Çakır, Betul Okuyan, Tugba Tunali-Akbay
https://www.sciencedirect.com/science/article/abs/pii/S0014299920308736
34. Predicting mortality in SARS-COV-2 (COVID-19) positive patients in the inpatient setting using a novel deep neural network
International Journal of Medical Informatics, 21 August 2021, Volume 154, Article 104556
Maleeha Naseem, Hajra Arshad, Fahad Shabbir Ahmed
https://www.sciencedirect.com/science/article/pii/S1386505621001829/pdfft?md5=8bb31f1f90f4f7494a9b3692da503c19&pid=1-s2.0-S1386505621001829-main.pdf
35. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory
Medical Hypotheses, 23 November 2020, Volume 146, Article 110412
Maurizio Carcaterra, Cristina Caruso
https://www.sciencedirect.com/science/article/abs/pii/S030698772033303X
36. SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy
Clinical Neurology and Neurosurgery, 29 December 2020, Volume 201 (Cover date: February 2021), Article 106451
Monika Adamczyk-Sowa, Hubert Mado, Paweł Sowa
https://www.sciencedirect.com/science/article/abs/pii/S0303846720307940
37. Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
Annals of Hepatology, 21 October 2020, Volume 20 (Cover date: January–February 2021), Article 100271
Ivan Lopez-Mendez, Jorge Aquino-Matus, Graciela Castro-Narro
https://www.sciencedirect.com/science/article/pii/S1665268120301861/pdfft?md5=654d61c88b8d5e0debb55e1f5054a699&pid=1-s2.0-S1665268120301861-main.pdf
38. Neurological complications associated with coronavirus disease-2019 (COVID-19): MRI features
Heliyon, 26 August 2021, Volume 7, Issue 8, Article e07879
Neven Moustafa Hazzaa
https://www.sciencedirect.com/science/article/pii/S2405844021019824/pdfft?md5=3e6bb4eab7252082ec0d218f5a058f50&pid=1-s2.0-S2405844021019824-main.pdf
39. SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in Brazil
The Brazilian Journal of Infectious Diseases, May–June 2021, Volume 25, Issue 3, Article 101595
Fernanda Salomão Gorayeb-Polacchini, Heloisa Cristina Caldas, Mario Abbud-Filho
https://www.sciencedirect.com/science/article/pii/S1413867021000647/pdfft?md5=a6e4ffadd4d3be7ea2d4da2fd4072f16&pid=1-s2.0-S1413867021000647-main.pdf
40. Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA
The Journal of Molecular Diagnostics, 21 January 2021, Volume 23, Issue 4, Pages 407-416
Laura Mannonen, Hannimari Kallio-Kokko, Maija Lappalainen
https://www.sciencedirect.com/science/article/pii/S1525157821000076/pdfft?md5=3cdc80551dd49d7207948473f5a701ee&pid=1-s2.0-S1525157821000076-main.pdf
41. Preoperative Chest Computed Tomography Screening for Coronavirus Disease 2019 in Asymptomatic Patients Undergoing Cardiac Surgery
Seminars in Thoracic and Cardiovascular Surgery, 17 October 2020, Volume 33, Issue 2, Pages 417-424
Wiebe G. Knol, Daniel J. F. M. Thuijs, Ricardo P. J. Budde
https://www.sciencedirect.com/science/article/pii/S1043067920303002/pdfft?md5=fbdc230bc84aea354b26e2f489b96dcc&pid=1-s2.0-S1043067920303002-main.pdf
42. Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy
Genomics, 20 January 2021, Volume 113, Issue 2, Pages 564-575
Henry Sung-Ching Wong, Chin-Lin Guo, Wei-Chiao Chang
https://www.sciencedirect.com/science/article/abs/pii/S0888754321000252
43. Comparative Analysis of Nanomechanical Features of Coronavirus Spike Proteins and Correlation with Lethality and Infection Rate
Matter, 2 November 2020, Volume 4, Issue 1 (Cover date: 6 January 2021), Pages 265-275
Yiwen Hu, Markus J. Buehler
https://www.sciencedirect.com/science/article/abs/pii/S2590238520306160
44. Comparative Host Interactomes of the SARS-CoV-2 Nonstructural Protein 3 and Human Coronavirus Homologs
Molecular & Cellular Proteomics, 27 June 2021, Volume 20, Article 100120
Katherine M. Almasy, Jonathan P. Davies, Lars Plate
https://www.sciencedirect.com/science/article/pii/S153594762100092X/pdfft?md5=acb99534e09b6268349d0027c105a5f9&pid=1-s2.0-S153594762100092X-main.pdf
45. Antibody profile in symptomatic/asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected Saudi persons
Saudi Journal of Biological Sciences, 3 May 2021, Volume 28, Issue 8, Pages 4677-4682
Essam H. Ibrahim, Mohammad Y. Alshahrani, Mona Kilany
https://www.sciencedirect.com/science/article/pii/S1319562X2100351X/pdfft?md5=0be1c5aaa564942ca4d482225de05c39&pid=1-s2.0-S1319562X2100351X-main.pdf
46. Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19
Medical Hypotheses, 16 November 2020, Volume 146 (Cover date: January 2021), Article 110363
Francisco E. Ramirez, Albert Sanchez, Aki T. Pirskanen
https://www.sciencedirect.com/science/article/pii/S0306987720332540/pdfft?md5=a70b4d9b49ed3b4b88fbd8e057791f3d&pid=1-s2.0-S0306987720332540-main.pdf
47. Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
Diabetes Research and Clinical Practice, 28 August 2021, Volume 179, Article 109031
Timotius Ivan Hariyanto, Denny Intan, Andree Kurniawan
https://www.sciencedirect.com/science/article/pii/S0168822721003909/pdfft?md5=7a6a0b77e8c82ec55a5611ef99dff61c&pid=1-s2.0-S0168822721003909-main.pdf
48. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection
Microbial Pathogenesis, 3 November 2020, Volume 152 (Cover date: March 2021), Article 104554
Hossein Khorramdelazad, Mohammad Hossein Kazemi, Reza Falak
https://www.sciencedirect.com/science/article/abs/pii/S0882401020309207
49. Vertical transmission and kidney damage in newborns whose mothers had coronavirus disease 2019 during pregnancy
International Journal of Antimicrobial Agents, 9 December 2020, Volume 57, Issue 2 (Cover date: February 2021), Article 106260
Zheng He, Yinian Fang, Dong Liu
https://www.sciencedirect.com/science/article/abs/pii/S0924857920304805
50. Seroprevalence of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers in Makkah, Saudi Arabia
Journal of King Saud University - Science, 13 February 2021, Volume 33, Issue 3, Article 101366
Waleed A. Ahmed, Ashraf Dada, Esam I. Azhar
https://www.sciencedirect.com/science/article/pii/S1018364721000276/pdfft?md5=b2354dc145e5a25362a94e1ce16bf29d&pid=1-s2.0-S1018364721000276-main.pdf
PUBMED:
1. A human coronavirus evolves antigenically to escape antibody immunity
Eguia RT, Crawford KHD, Stevens-Ayers T, Kelnhofer-Millevolte L, Greninger AL, Englund JA, Boeckh MJ, Bloom JD.
PLoS Pathog. 2021 Apr 8;17(4):e1009453
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031418/pdf/ppat.1009453.pdf
2. Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability
Kim YS, Aigerim A, Park U, Kim Y, Park H, Rhee JY, Choi JP, Park WB, Park SW, Kim Y, Lim DG, Choi JY, Jeon YK, Yang JS, Lee JY, Shin HS, Cho NH.
Clin Infect Dis. 2021 Aug 2;73(3):e550-e558
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499518/pdf/ciaa1345.pdf
3. Sub-second heat inactivation of coronavirus using a betacoronavirus model
Jiang Y, Zhang H, Wippold JA, Gupta J, Dai J, de Figueiredo P, Leibowitz JL, Han A.
Biotechnol Bioeng. 2021 May;118(5):2067-2075
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013827/pdf/BIT-9999-0.pdf
4. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues
Persoons L, Vanderlinden E, Vangeel L, Wang X, Do NDT, Foo SC, Leyssen P, Neyts J, Jochmans D, Schols D, De Jonghe S.
Antiviral Res. 2021 Sep;193:105127
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247284/pdf/main.pdf
5. Increased survivability of coronavirus and H1N1 influenza virus under electrostatic aerosol-to-hydrosol sampling
Piri A, Kim HR, Park DH, Hwang J.
J Hazard Mater. 2021 Jul 5;413:125417.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879034/pdf/main.pdf
6. Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity
Asthana A, Gaughan C, Dong B, Weiss SR, Silverman RH.
mBio. 2021 Aug 31;12(4):e0178121.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406329/pdf/mbio.01781-21.pdf
7. Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity
Guzmán-Martínez O, Guardado K, Varela-Cardoso M, Trujillo-Rivera A, Gómez-Ñañez I, Ortiz-León MC, Espinosa R, Ramos C, Pérez-Carreón JI, López-Guerrero DV, Sampieri CL, Alanís-García AB, Rojas-Durán F, Zenteno-Cuevas R, Gutiérrez M, Montero H.
Int J Environ Res Public Health. 2021 Aug 27;18(17):9058
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430483/pdf/ijerph-18-09058.pdf
8. Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis
Du PX, Chou YY, Santos HM, Keskin BB, Hsieh MH, Ho TS, Wang JY, Lin YL, Syu GD.
Anal Chem. 2021 Jun 1;93(21):7690-7698.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146142/pdf/ac1c00614.pdf
9. Updated and Validated Pan-Coronavirus PCR Assay to Detect All Coronavirus Genera
Holbrook MG, Anthony SJ, Navarrete-Macias I, Bestebroer T, Munster VJ, van Doremalen N.
Viruses. 2021 Apr 1;13(4):599
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067199/pdf/viruses-13-00599.pdf
10. Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication
Adams LE, Dinnon KH 3rd, Hou YJ, Sheahan TP, Heise MT, Baric RS.
mBio. 2021 Mar 16;12(2):e03149-20
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092278/pdf/mBio.03149-20.pdf
SPRINGER NATURE
1. Sudden Sensorineural Hearing Loss Post Coronavirus Disease: A Systematic Review of Case Reports
Abishek Umashankar, Praveen Prakash… in Indian Journal of Otolaryngology and Head … (2021)
https://link.springer.com/content/pdf/10.1007%2Fs12070-021-02756-w.pdf
2. Analysis of the Genomic Distance Between Bat Coronavirus RaTG13 and SARS-CoV-2 Reveals Multiple Origins of COVID-19
Shaojun Pei 裴少君, Stephen S.-T. Yau 丘成栋 in Acta Mathematica Scientia (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10473-021-0323-x.pdf
3. Deep Learning in Classification of Covid-19 Coronavirus, Pneumonia and Healthy Lungs on CXR and CT Images
Mihaela-Ruxandra Lascu in Journal of Medical and Biological Engineering (2021)
https://link.springer.com/content/pdf/10.1007%2Fs40846-021-00630-2.pdf
4. Quantitative analysis based on chest CT classifies common and severe patients with coronavirus disease 2019 pneumonia in Wuhan, China
Chongtu Yang, Guijuan Cao, Fen Liu, Jiacheng Liu… in Chinese Journal of Academic Radiology (2021)
https://link.springer.com/content/pdf/10.1007%2Fs42058-021-00061-7.pdf
5. Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019
Vadim Lesan, Moritz Bewarder, Carlos Metz… in Intensive Care Medicine Experimental (2021)
https://link.springer.com/content/pdf/10.1186%2Fs40635-021-00409-4.pdf
6. Hemodialysis patients with coronavirus disease 2019: reduced antibody response
Hiroko Beppu, Tatsuya Fukuda, Tomoko Kawanishi… in Clinical and Experimental Nephrology (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10157-021-02130-8.pdf
7. Neurological manifestations of coronavirus disease 2019: exploring past to understand present
Ishita Desai, Rajat Manchanda, Niraj Kumar, Ashutosh Tiwari… in Neurological Sciences (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10072-020-04964-8.pdf
8. Glycemic status affects the severity of coronavirus disease 2019 in patients with diabetes mellitus: an observational study of CT radiological manifestations using an artificial intelligence algorithm
Xiaoting Lu, Zhenhai Cui, Feng Pan, Lingli Li, Lin Li, Bo Liang… in Acta Diabetologica (2021)
https://link.springer.com/content/pdf/10.1007%2Fs00592-020-01654-x.pdf
9. Extracorporeal Membrane Oxygenation Therapy for Critically Ill Coronavirus Disease 2019 Patients in Wuhan, China: A Retrospective Multicenter Cohort Study
Jing Fang, Rui Li, Yue Chen, Juan-juan Qin, Ming Hu… in Current Medical Science (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11596-021-2311-8.pdf
10. Drug screening and development from the affinity of S protein of new coronavirus with ACE2
Yue-Peng Jiang, Xiao-Xuan Zhao, Hui-Qing Lv… in European Journal of Clinical Microbiology y & Infectious Diseases (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10096-020-04048-7.pdf
Các công bố về COVID-19 trước thời gian trên:
Cập nhật các công bố về COVID-19 từ ngày 27/08 đến ngày 03/09/2021
https://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-8-den-ngay-3-9-2021-3953.html
Cập nhật các công bố về COVID-19 từ ngày 20/08 đến ngày 27/08/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-20-8-den-ngay-27-8-2021-3932.html
Cập nhật các công bố về COVID-19 từ ngày 13/08 đến ngày 20/08/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-13-8-den-ngay-20-8-2021-3904.html
Cập nhật các công bố về COVID-19 từ ngày 06/08 đến ngày 13/08/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-6-8-den-ngay-13-8-2021-3878.html
Cập nhật các công bố về COVID-19 từ ngày 30/07 đến ngày 06/08/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-7-den-ngay-6-8-2021-3849.html
Cập nhật các công bố về COVID-19 từ ngày 23/07 đến ngày 30/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-7-den-ngay-30-7-2021-3823.html
Cập nhật các công bố về COVID-19 từ ngày 16/07 đến ngày 23/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-07-den-ngay-23-07-2021-3797.html
Cập nhật các công bố về COVID-19 từ ngày 09/07 đến ngày 16/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-07-den-ngay-16-07-2021-3769.html
Cập nhật các công bố về COVID-19 từ ngày 02/07 đến ngày 09/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-7-2021-den-ngay-9-7-2021-3744.html
Cập nhật các công bố về COVID-19 từ ngày 25/06 đến ngày 02/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-25-6-den-ngay-02-7-2021-3716.html
Cập nhật các công bố về COVID-19 từ ngày 18/06 đến ngày 25/06/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-6-den-ngay-25-6-2021-3692.html
Cập nhật các công bố về COVID-19 từ ngày 11/06 đến ngày 18/06/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-11-06-den-ngay-18-06-2021-3663.html
Cập nhật các công bố về COVID-19 từ ngày 04/06 đến ngày 11/06/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-04-06-den-ngay-11-6-2021-3642.html
Cập nhật các công bố về COVID-19 từ ngày 28/05 đến ngày 04/06/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-28-05-den-ngay-04-06-2021-3624.html
Cập nhật các công bố về COVID-19 từ ngày 21/05 đến ngày 28/05/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-05-den-ngay-28-05-2021-3598.html
Cập nhật các công bố về COVID-19 từ ngày 14/05 đến ngày 21/05/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-14-05-den-ngay-21-05-2021-3582.html
Cập nhật các công bố về COVID-19 từ ngày 07/05 đến ngày 14/05/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-05-den-ngay-14-05-2021-3557.html
Cập nhật các công bố về COVID-19 từ ngày 30/04 đến ngày 07/05/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-04-den-ngay-07-05-2021-3530.html
Cập nhật các công bố về COVID-19 từ ngày 23/04 đến ngày 30/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-04-den-ngay-30-04-2021-3509.html
Cập nhật các công bố về COVID-19 từ ngày 16/04 đến ngày 23/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-04-den-ngay-23-04-2021-3484.html
Cập nhật các công bố về COVID-19 từ ngày 09/04 đến ngày 16/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-04-den-ngay-19-04-2021-3474.html
Cập nhật các công bố về COVID-19 từ ngày 02/04 đến ngày 09/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-04-den-ngay-09-04-2021-3432.html
Cập nhật các công bố về COVID-19 từ ngày 26/03 đến ngày 02/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-03-den-ngay-02-04-2021-3408.html
Cập nhật các công bố về COVID-19 từ ngày 19/03 đến ngày 26/03/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-03-den-ngay-26-03-2021-3386.html
Cập nhật các công bố về COVID-19 từ ngày 12/03 đến ngày 19/03/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-12-3-den-ngay-19-3-2021-3376.html
Cập nhật các công bố về COVID-19 từ ngày 26/02 đến ngày 04/03/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-02-den-ngay-4-3-2021-3336.html
Cập nhật các công bố về COVID-19 từ ngày 09/02 đến ngày 25/02/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-02-den-ngay-25-02-2021-3319.html
Cập nhật các công bố về COVID-19 từ ngày 23/01 đến ngày 29/01/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-01-den-ngay-29-01-2021-3250.html
Cập nhật các công bố về COVID-19 từ ngày 09/01 đến ngày 15/01/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-01-den-ngay-15-01-2021-3211.html
Cập nhật các công bố về COVID-19 từ ngày 18/12 đến ngày 24/12/2020
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-12-den-ngay-24-12-2020-3174.html
Cập nhật các công bố về COVID-19 từ ngày 05/12 đến ngày 17/12/2020
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-12-den-ngay-17-12-2020-3160.html
Cập nhật các công bố về COVID-19 từ ngày 15/11 đến ngày 22/11/2020
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-11-den-ngay-22-11-2020-3123.html
Cập nhật các công bố về COVID-19 từ ngày 02/10 đến ngày 09/11/2020
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-10-den-ngay-09-11-2020-3107.html
Cập nhật các công bố về COVID-19 từ ngày 26/9 đến ngày 02/10/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-9-den-ngay-02-10-2020-3027.html
Cập nhật các công bố về COVID-19 từ ngày 19/9 đến ngày 25/9/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-9-den-ngay-25-9-2020-3010.html
Cập nhật các công bố về COVID-19 từ ngày 05/9 đến ngày 11/9/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-9-den-ngay-11-9-2020-2969.html
Cập nhật các công bố về COVID-19 từ ngày 29/8 đến ngày 04/9/2020
http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-29-8-den-ngay-04-9-2020-2944.html
Cập nhật các công bố về COVID-19 từ ngày 21/8 đến ngày 28/8/2020
http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-8-den-ngay-28-8-2020-2929.html
Cập nhật các công bố về VACCINE COVID-19 tháng 8 năm 2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-vaccine-covid-19-2900.html
Cập nhật các công bố về COVID-19 từ ngày 08/8 đến ngày 14/8/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-8-den-ngay-14-8-2020-2866.html
Cập nhật các công bố về COVID-19 từ ngày 27/7 đến ngày 07/8/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-7-den-ngay-07-8-2020-2826.html
Cập nhật các công bố về COVID-19 từ ngày 15/7 đến ngày 26/7/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-7-den-ngay-26-7-2020-2779.html
Cập nhật các công bố về COVID-19 từ ngày 05/7 đến ngày 13/7/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-7-den-ngay-13-7-2020-2723.html
Cập nhật các công bố về COVID-19 từ ngày 22/6 đến ngày 30/6/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-22-6-den-ngay-30-6-2020-2681.html
Cập nhật các công bố về COVID-19 từ ngày 15/6 đến ngày 21/6/2020
https://www.most.gov.vn/vn/tin-tuc/17959/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-6-den-ngay-21-6-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 07/6 đến ngày 14/6/2020
http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-6-den-ngay-14-6-2020-2580.html
Cập nhật các công bố về COVID-19 đến ngày 07/6/2020
http://www.vista.gov.vn/news/khoa-hoc-ky-thuat-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-01-6-den-ngay-07-6-2020-2553.html
Cập nhật các công bố về COVID-19 đến ngày 01/6/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-den-ngay-01-6-2020-2524.html
Cập nhật các công bố về COVID-19 từ ngày 15/5 tới ngày 21/5/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-5-den-ngay-24-5-2020-2478.html
Cập nhật các công bố về COVID-19 từ ngày 08/5 tới ngày 14/5/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-5-den-ngay-14-5-2020-2436.html
Cập nhật các công bố về COVID-19 từ ngày 30/4 tới ngày 07/5/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-4-den-ngay-07-5-2020-2406.html
Cập nhật các công bố về COVID-19 từ ngày 24/4 tới ngày 30/4/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-24-4-den-ngay-30-4-2020-2375.html
Cập nhật các công bố về COVID-19 từ ngày 17/4 tới ngày 23/4/2020
https://www.most.gov.vn/vn/tin-tuc/17695/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-17-4-den-ngay-23-4-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 10/4 tới ngày 16/4/2020
https://www.most.gov.vn/vn/tin-tuc/17655/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-10-4--den-ngay-16-4-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 03/4 tới ngày 09/4/2020
https://www.most.gov.vn/vn/tin-tuc/17630/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-3-4--den-ngay-9-4-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 27/3 tới ngày 02/4/2020
https://www.most.gov.vn/vn/tin-tuc/17609/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-3-den-ngay-02-4-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 20/3 tới ngày 26/3/2020
https://www.most.gov.vn/vn/tin-tuc/17597/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-20-3-den-ngay-26-3-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 13/3 tới ngày 19/3/2020
https://www.most.gov.vn/vn/tin-tuc/17575/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-13-3-den-ngay-19-3-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 06/3 tới ngày 12/3/2020
https://www.most.gov.vn/vn/tin-tuc/17547/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-06-3-den-ngay-12-3-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 28/02 tới ngày 05/3/2020
http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20781/language/vi-VN/Default.aspx?seo=Cap-nhat-cac-cong-bo-moi-ve-COVID-19-den-ngay-05/3/2020&language=vi-VN
Cập nhật các công bố về COVID-19 từ ngày 11/02 tới ngày 27/02/2020
http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20740/seo/20740/language/vi-VN/language/vi-VN/Default.aspx
Cập nhật các công bố về virus corona từ tháng 11/2019 tới ngày 10/02/2020
http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20678/seo/20678/language/vi-VN/Default.aspx
Theo vista.gov.vn
